Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects
Clinical trial NCT02591290 · COMPLETED
Trial details
- NCT number
- NCT02591290
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-20
- Primary completion
- 2016-03-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.